У нас вы можете посмотреть бесплатно Life-changing neurological improvement after treatment by Edward Tobinick MD или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Life-changing improvement after perispinal etanercept (PSE) treatment by Edward Tobinick MD at the Institute of Neurological Recovery in Boca Raton. PSE treatment (single dose) was administered in December 2018. This video was filmed March 22, 2019, 3 1/2 months after treatment. Wife reports sustained and life-changing neurological improvement after a single dose of PSE. PSE treatment was given 2 1/2 years after brain injury due to prolonged cardiac arrest. Additional Information: Florida Doctor Gives Stroke Patients a New Shot at Mobility, Independence: https://bit.ly/3phc56k Edward Tobinick, M.D. Information: https://bit.ly/36JE4Fx Edward Tobinick, M.D. Google Scholar: https://bit.ly/3heyKvT On Overcoming Barriers to Neuroinflammation Research (Tobinick, et al): https://bit.ly/3tcxIGf LEARN MORE: https://www.strokebreakthrough.com/ REQUEST A CONSULTATION TODAY: SEE MORE STROKE VIDEOS: https://bit.ly/36BqvYx YOUTUBE CHANNEL: https://bit.ly/3M5HbYk CALL: +1 (561) 353-9707 Disclaimer: Individual results vary, not all patients respond. Additional treatment doses may be necessary to maintain the clinical response. Treatment for this indication is off-label. Please see the Terms of Use (http://www.strokebreakthrough.com/abo.... The method of treatment utilized is a patented invention of the INR®. Issued and pending U.S. and foreign patents, including U.S. patents 8,236,306; 8,349,323; 8,900,583; 9,808,523; Australian patent 2011323616 B2, Canadian patent 2,811,948, European patent ES2620749 (T3), etc., all assigned to TACT IP LLC. © 2019 INR PLLC, all rights reserved.